Spots Global Cancer Trial Database for JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Official Title: A Multicenter, Retrospective, Observational Study of Avelumab Maintenance and Subsequent Therapies in Japanese Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Study ID: NCT06412848
Conditions
Interventions
Study Description
Brief Summary: This study is a multicenter, non-interventional, retrospective, medical chart review of locally advanced or metastatic (la/m) Urothelial Cancer UC participants who were prescribed avelumab as first line maintenance therapy after a platinum-based chemotherapy. This study aims to understand the index date (i.e., at the initiation of avelumab maintenance therapy) demographics and clinical characteristics of participants with locally advanced/metastatic Urothelial Carcinoma in Japan, and to describe their treatment patterns and outcomes.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hirosaki University Hospital, Hirosaki, Aomori, Japan
Ehime University Hospital, Toon, Ehime, Japan
Kurume University Hospital, Kurume, Fukuoka, Japan
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan
Kobe University Hospital, Kobe, Hyogo, Japan
Iwate Medical University Hospital, Shiwa-gun, Iwate, Japan
Kagawa University Hospital, Kita-gun, Kagawa, Japan
St. Marianna University Hospital, Kawasaki, Kanagawa, Japan
Kitasato University Hospital, Sagamihara, Kanagawa, Japan
Nara Medical University Hospital, Kashihara, Nara, Japan
Kindai University Hospital, Osakasayama, Osaka, Japan
Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
Juntendo University Hospital, Bunkyo-ku, Tokya, Japan
Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Teikyo University Hospital, Itabashi-ku, Tokyo, Japan
Akita University Hospital, Akita, , Japan
Kyushu Cancer Center, Fukuoka, , Japan
Kumamoto University Hospital, Kumamoto, , Japan
University Hospital Kyoto Prefectural University of Medicine, Kyoto, , Japan
Kyoto University Hospital, Kyoto, , Japan
Osaka International Cancer Institute, Osaka, , Japan
Tokushima University Hospital, Tokushima, , Japan
Toyama University Hospital, Toyama, , Japan
Yamagata University Hospital, Yamagata, , Japan
Contact Details
Name: Medical Responsible
Affiliation: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
